MAPT and neurodegenerative disease: Importantly, we and others have shown that the PMCA and RT-QuIC amplification technologies can be successfully adapted for high sensitive detection of Aβ, tau and α-syn aggregates in human biological fluids37–41, offering the promise that this assay could be used for biochemical diagnosis of neurodegenerative diseases and perhaps to further increase the safety of biological products.